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works for HTA. This study seeks to systematically review the literature to identify 
existing ethics frameworks for HTA in order to provide an overview of their method-
ological features and to gain a better understanding of the areas of commonality and 
divergence between different frameworks. Methods: We conducted a systematic 
search of literature, without limits of time and language, to identify the guidance 
documents or practical frameworks published up to October 1st 2013. Results: The 
review identified 22 frameworks, varying in their philosophical approach, structure, 
and comprehensiveness. They were designed for different purposes throughout the 
HTA process, ranging from helping HTA producers in identification, appraisal and 
analysis of ethical data to supporting decision-makers in making better informed 
value-sensitive decisions. They frequently promoted analytical methods that com-
bined normative reflection with descriptive approaches to the analysis of values of 
stakeholders and other societal or technical actors. ConClusions: The choice of a 
method for collection and analysis of ethical data seems to depend on the context 
in which technology is being assessed, the purpose of analysis, and availability of 
required resources.
ReseaRch on Methods – statistical Methods
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coMPaRing PRoPensity scoRe, PRoPensity scoRe with covaRiates 
and genetic algoRithM Methods foR covaRiate Matching in 
obseRvational studies
Claeys C., Bakken D.G., Wasserman D., Spilman J.
KJT Group, Inc., Honeoye Falls, NY, USA
objeCtives: As the population ages an increasing number of individuals are provid-
ing informal (unpaid) care for an aging relative. We compare three different methods 
of covariate matching to determine the effect of caregiving on the mental health 
states of informal caregivers. Covariate matching methods pair observations from 
different treatment groups by matching the members of each pair on a set or vector 
of covariates that would be randomly distributed across the groups in a randomized 
trial. Methods: Multiple waves of an online survey conducted among a representa-
tive sample of U.S. adults yielded 740 informal caregivers and 2260 non-caregivers. 
We applied three different methods for covariate matching to determine the “aver-
age effect of treatment on the treated” (ATT) of caregiving on mental health states 
(MH): 1. Propensity score within calipers; 2. Propensity score and covariates within 
calipers; and 3. Genetic algorithm matching. Results: All three methods provide 
adequate balance on the covariates used for matching. Methods 2 and 3 produce 
the best covariate balance, with absolute mean covariate differences less 0.0008 on 
all covariates and less than 0.00001 on the core set of covariates. Because methods 
that censor observations (i.e. matching within calipers) may artificially improve 
covariate balance, we take the ATT estimate from genetic matching to be the least 
biased estimate of the true effect. Using a standard 5-point self-report measure of 
mental health, caregivers, on average, report a mental health state that is 5.4% worse 
than non-caregivers (roughly one-fourth “less healthy” within any given scale range 
(e.g. 2-3, 3-4). ConClusions: As all three methods provide adequate matching, our 
consideration turns to bias reduction and the fact that the genetic matching does 
not require that we estimate the propensity score prior to matching. We consider 
the drivers or caregiver MH and implications for health care policy.
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objeCtives: To compare the quality and transparency of industry supported network 
meta-analyses with those with non-profit support or no support. Methods: We sys-
tematically searched OVID-Medline for network meta-analyses including at least one 
pharmaceutical. We reviewed each network meta-analysis and evaluated key general 
study characteristics, methodology, and transparency using a checklist of objective 
criteria derived from the ISPOR Taskforce’s recommendations for study conduct and 
reporting. We reported source of study funding when available. When source of fund-
ing was unclear or not reported we contacted the corresponding author. We compared 
the quality and transparency of industry supported network meta-analyses with 
those with non-profit support or no support. Results: Two hundred and fourteen 
studies met our inclusion criteria and were included in our dataset. Source of fund-
ing was identified for 211 studies (98.6%). Industry supported studies tended to be 
published in lower quality medical journals (p< 0.01), and typically included fewer 
studies (p< 0.05) and a smaller total number of patients (p< 0.05). In terms of study 
transparency, industry supported studies less often reported the search terms (p< 0.01) 
and, for analyses conducted using a Bayesian framework, presented the model code 
(p< 0.01). Regarding study methodology, industry supported network meta-analyses 
less often reported a quality assessment of clinical studies included in the network 
meta-analysis (p< 0.01), and less often compared the findings of traditional meta-
analysis and network meta-analysis (p< 0.01). With respect to presentation of findings, 
industry supported studies less often reported the full matrix of head-to-head com-
parisons (p< 0.01), or provided a ranking of treatments (p< 0.01). ConClusions: We 
found that studies with non-profit support or no support funded tended to be more 
transparent and rigorous than industry supported studies. Study findings emphasize 
that users of network meta-analyses should take great care to account for study qual-
ity when interpreting the findings of network meta-analyses.
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PRogRaMMing: a case study in caRdiovasculaR disease
Bannister C.A., Currie C.J., Preece A., Spasic I.
Cardiff University, Cardiff, UK
countries were the following: (1) keep the same date, event, and consequences 
whenever possible (i.e., Tuesday May 4, a 3 alarm fire, destruction of two hotels 
and one restaurant); and (2) substitute the place where the event is located [i.e., 
a city (Cleveland, Ohio)] with a place familiar to the subjects living in the target 
countries. Results: The event (fire) could be kept in all countries. The date had 
to be changed in The Netherlands because it corresponds to a commemoration 
(Remembrance of the Dead) and would have introduced a bias if kept. The verbatim 
“a 3 alarm fire” was impossible to translate literally since no equivalent fire-classifi-
cation system is used in most target countries (except in Canada). It was decided to 
use synonyms of “big” to qualify “fire.” Syntax was also an issue especially in Korea, 
Japan, Romance and Germanic languages where the order of some segments had 
to be inverted. ConClusions: Although simple in its structure, the RBANS story 
memory-test proved to be challenging to translate into 24 languages and required 
a rigorous methodology to preserve the intent of the original.
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standaRdization of Mental health assessMent – using iteM 
ResPonse theoRy (iRt) to cRoss-calibRate two self-RePoRted Mental 
health tools: the Patient health questionnaiRe (Phq-9) and the sf-
36v2 Mental health (Mh) scale
Bjorner J.B., White M.K., Yarlas A.S.
Optum, Lincoln, RI, USA
objeCtives: Mental health can be measured by numerous instruments, but scores 
are usually not directly comparable. The heterogeneity of scale specific metrics seri-
ously impairs comparability across study results and the communication among 
researchers and clinicians. We aimed to develop and evaluate methods for cross-
calibration of two popular mental health tools: the PHQ-9 and the SF-36v2 MH 
scale. Methods: We analyzed data from the United States and the UK including a 
general population sample (US: 216, UK: 355) and a sample with suspected depres-
sion (US: 169, UK: 153). Multigroup confirmatory bifactor models tested whether 
the two instruments measured the same construct. Differential item function 
(DIF) between general population and depression samples was tested using logis-
tic regression DIF tests. We estimated IRT item parameters using a multigroup 
generalized partial credit model and developed cross-calibration algorithms using 
the summed score cross-calibration approach. The measurement properties of the 
instruments were evaluated by test information functions. Results: In the bifactor 
model, all items loaded strongly on a common factor, supporting that the two scales 
measure the same general mental health construct. We found no indication of DIF, 
supporting that the same item parameters apply to the general population and the 
depression samples. The cross-calibration algorithm revealed a fairly linear relation 
between PHQ-9 score and MH score in the PHQ-9 score range of 10-20 (moderate 
to severe depression), but a non-linear relation at more extreme scores. The PHQ-9 
provided most information for persons with scores in the interval from the general 
population average down to two standard deviations below average, but the MH 
scale provided more information at the lower and upper extremes. ConClusions: 
We successfully developed a procedure for cross-calibrating the PHQ-9 and MH 
scales. These results can be used to compare scores between the two instruments.
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objeCtives: Mapping between health status measures is common practice within 
health economic evaluations. The objective of this analysis was to evaluate the suit-
ability of hold-out validation, whereby models are fitted to a subset of data and then 
tested in the remaining observations, compared to other methods of internal valida-
tion utilising full sample approaches in small to medium sized samples. Methods: 
Four models predicting EQ-5D from the SF-12 were estimated using the Medical 
Expenditure Panel Survey. Models were estimated using three hypothetical sample 
sizes of 500, 1,000, and 4,000 observations. For each model and sample size, two 
hold-out validation specifications were compared against alternative estimators of 
error: the naïve resubstitution error; repeated 10-fold cross validation; the optimism-
corrected bootstrap; the 0.632 bootstrap. The results from these estimators were 
compared against asymptotic estimates of the true error indices in the remaining 
observations (n= 15,675). Estimators were evaluated by assessment of bias and vari-
ance. The exercise was repeated 500 times. Results: Hold-out methods were subject 
to the largest variance across all estimators and sample sizes. Variance was lower 
and similar in the full sample estimators (bootstrap and cross-validation methods). 
The extent of bias in any sample size was associated with the degree to which the 
algorithms were adaptive to the training sample data. For the two mapping algorithms 
which were not adaptive to the training sample data, bias was low for all estimators. 
In the two algorithms which were more adaptive to the training sample data, the 
naïve resubstitution error was associated with a downward bias, hold-out methods 
exhibited an upward bias, and all full sample methods exhibited a low degree of 
bias. ConClusions: Hold-out validation exhibited the highest variance of all meth-
ods in all scenarios. Full-sample designs offer lower variance and are preferable to 
continued use of hold-out validation with small to medium sized datasets.
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a systeMatic Review of Methodological fRaMewoRks foR 
evaluation of ethical consideRations in health technology 
assessMent
Assasi N., Schwartz L., Tarride J.E., Campbell K., Goeree R.
McMaster University, Hamilton, ON, Canada
objeCtives: While advances have been made in development of ethical frame-
works for health technology assessment (HTA), there is no clear agreement on the 
most useful and practical approach to address ethical aspects in HTA. Moreover, 
uncertainty remains about appropriate scope and level of details of ethical frame-
